publication . Article . 2017

bactericidal activity of herbal volatile oil extracts against multidrug resistant acinetobacter baumannii

Intorasoot, Amornrat; Chornchoem, Piyaorn; Sookkhee, Siriwoot; Intorasoot, Sorasak;
Open Access
  • Published: 01 Apr 2017 Journal: Journal of Intercultural Ethnopharmacology, volume 6, page 1 (eissn: 2146-8397, Copyright policy)
  • Publisher: ScopeMed International Medical Journal Management and Indexing System
Abstract
Aim: To investigate the antibacterial activity of ten volatile oils extracted from medicinal plants, including galangal (Alpinia galanga Linn.), ginger (Zingiber officinale), plai (Zingiber cassumunar Roxb.), lime (Citrus aurantifolia), kaffir lime (Citrus hystrix DC.), sweet basil (Ocimum basilicum Linn.), tree basil (Ocimum gratissimum), lemongrass (Cymbopogon citratus DC.), clove (Syzygium aromaticum) and cinnamon (Cinnamomum verum) against four standard strains of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii and thirty clinical isolates of multidrug-resistant A. baumannii (MDR-A. baumannii). Methods: Agar diffusion...
Subjects
free text keywords: Zingiber cassumunar, biology.organism_classification, biology, Acinetobacter baumannii, Tea tree oil, medicine.drug, medicine, Botany, Cinnamomum verum, Ocimum gratissimum, Alpinia galanga, food.ingredient, food, Ocimum, Traditional medicine, Microbiology, Minimum bactericidal concentration, MDR-Acinetobacter baumannii, volatile oil, medicinal plant, Miscellaneous systems and treatments, RZ409.7-999, Therapeutics. Pharmacology, RM1-950, Original Research, multidrug-resistant-Acinetobacter baumannii
Related Organizations
33 references, page 1 of 3

World Health Organization (WHO). Global priority list of antibioticresistant bacteria to guide research, discovery, and development of new antibiotics. Geneva: Swiss; 2017. Available from: http://www.

who.int/medicines/publications/WHO-PPL-Short_Summary_251 FebET_NM_WHO.pdf. [Last accessed on 2017 Feb 25].

Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: Comparison of outbreak and sporadic isolates. J Clin Microbiol 1998;36:1938-41.

McConnell MJ, Actis L, Pachón J. Acinetobacter baumannii: Human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev 2013;37:130-55. [OpenAIRE]

4. Ahmed SS, Alp E, Hopman J, Voss A. Global epidemiology on colistin resistant Acinetobacter baumannii. J Infect Dis Ther 2016;4:1000287.

5. De Francesco MA, Ravizzola G, Peroni L, Bonfani C, Manca N. Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomnas aeruginosa in an Italian hospital. J Infect Public Health 2013;6:179-85.

6. Sukanya S, Lakshmi V, Padmaja K. Prevalence of multidrug resistant Acinetobacter baumannii in clinical samples in a tertiary care hospital. Int J Infect Control 2014;11:3.

7. Tunyapanit W, Pruekprasert P, Laoprasopwattana K, Chelae S. Antimicrobial susceptibility of Acinetobacter baumannii isolated from hospital patients. Sci Asia 2014;40:28-34. [OpenAIRE]

8. May J, Chan CH, King A, Williams L, French GL. Time-kill studies of tea tree oils on clinical isolates. J Antimicrob Chemother 2000;45:639-43.

9. Rivas da Silva AC, Lopes PM, Barros de Azevedo MM, Costa DC, Alviano CS, Alviano DS. Biological activities of alpha-pinene and β-pinene enantiomers. Molecules 2012;17:6305-16.

10. Constantiniu S, Romaniuc A, Iancu LS, Filimon R, Tarasi I. Culture and biochemical characteristics of Acinetobacter spp. Strains isolated from hospital units. J Prev Med 2004;12:35-42.

11. Wilson KH, Blitchington RB, Greene RC. Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. J Clin Microbiol 1990;28:1942-6.

12. CLSI. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard, M02-A11. 11th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.

13. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty- Second Informational Supplement, M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.

14. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81.

33 references, page 1 of 3
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue